Ausgabe 1/2013
Inhalt (9 Artikel)
Leading Article
Operationalizing Value-Based Pricing of Medicines
Jon Sussex, Adrian Towse, Nancy Devlin
Review Article
Pazopanib for the First-Line Treatment of Patients with Advanced and/or Metastatic Renal Cell Carcinoma
Mary Kilonzo, Jenni Hislop, Andrew Elders, Cynthia Fraser, Donald Bissett, Samuel McClinton, Graham Mowatt, Luke Vale
Systematic Review
A Systematic and Critical Review of the Evolving Methods and Applications of Value of Information in Academia and Practice
Lotte Steuten, Gijs van de Wetering, Karin Groothuis-Oudshoorn, Valesca Retèl
Systematic Review
The Humanistic and Economic Burden of Systemic Lupus Erythematosus
Rachel Meacock, Nicola Dale, Mark J. Harrison
Systematic Review
Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B
María Buti, Itziar Oyagüez, Virginia Lozano, Miguel A. Casado
Original Research Article
Timely and Complete Publication of Economic Evaluations Alongside Randomized Controlled Trials
Joanna C. Thorn, Sian M. Noble, William Hollingworth
Open Access
Correspondence
A Comment on Boyers et al.: “Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal”
Rachel Allen, Andres Brainsky, Kelly Grotzinger, Tito Roccia
Correspondence
The Authors’ Reply to Allen et al.: “A Comment on Boyers et al.: ‘Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal’”
Dwayne Boyers, Xueli Jia, David Jenkinson, Graham Mowatt